Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian M Jubb

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|December 4, 2010
Biomarkers to predict the clinical efficacy of bevacizumab in cancerAdrian M Jubb, Adrian L Harris
Annals of the New York Academy of Sciences|May 2, 2003
DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utilityAdrian M Jubb, Phil Quirke, Adam J Oates
Future Oncology (London, England)|July 14, 2010
Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicityJi-Liang Li, Adrian M Jubb, Adrian L Harris
The Journal of Pathology|October 15, 2013
Pathology in drug discovery and developmentAdrian M Jubb, Hartmut Koeppen, Jorge S Reis-Filho
Journal of Cellular and Molecular Medicine|October 21, 2009
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosisAdrian M Jubb, Francesca M Buffa, Adrian L Harris
Nature Reviews. Cancer|July 14, 2006
Predicting benefit from anti-angiogenic agents in malignancyAdrian M Jubb, Adam J Oates, Scott Holden, et al.
Journal of Clinical Pathology|August 4, 2012
Prognostic and predictive significance of proliferation in 867 colorectal cancersImola K Fodor, Gordon G Hutchins, Carmina Espiritu, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Quantitative in situ hybridization of tissue microarraysAdrian M Jubb, Thinh Q Pham, Gretchen D Frantz, et al.
The Journal of Pathology|October 26, 2011
Neuropilin-1 expression in cancer and developmentAdrian M Jubb, Laura A Strickland, Scot D Liu, et al.
Histopathology|March 6, 2012
Neuropilin-2 expression in cancerAdrian M Jubb, Susan M Sa, Navneet Ratti, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|December 4, 2010
Biomarkers to predict the clinical efficacy of bevacizumab in cancerAdrian M Jubb, Adrian L Harris
Annals of the New York Academy of Sciences|May 2, 2003
DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utilityAdrian M Jubb, Phil Quirke, Adam J Oates
Future Oncology (London, England)|July 14, 2010
Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicityJi-Liang Li, Adrian M Jubb, Adrian L Harris
The Journal of Pathology|October 15, 2013
Pathology in drug discovery and developmentAdrian M Jubb, Hartmut Koeppen, Jorge S Reis-Filho
Journal of Cellular and Molecular Medicine|October 21, 2009
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosisAdrian M Jubb, Francesca M Buffa, Adrian L Harris
Nature Reviews. Cancer|July 14, 2006
Predicting benefit from anti-angiogenic agents in malignancyAdrian M Jubb, Adam J Oates, Scott Holden, et al.
Journal of Clinical Pathology|August 4, 2012
Prognostic and predictive significance of proliferation in 867 colorectal cancersImola K Fodor, Gordon G Hutchins, Carmina Espiritu, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Quantitative in situ hybridization of tissue microarraysAdrian M Jubb, Thinh Q Pham, Gretchen D Frantz, et al.
The Journal of Pathology|October 26, 2011
Neuropilin-1 expression in cancer and developmentAdrian M Jubb, Laura A Strickland, Scot D Liu, et al.
Histopathology|March 6, 2012
Neuropilin-2 expression in cancerAdrian M Jubb, Susan M Sa, Navneet Ratti, et al.
Pageof 5